Front Barnett Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.18M Hold
16,600
0.14% 56
2023
Q2
$1.28M Sell
16,600
-2,000
-11% -$155K 0.14% 56
2023
Q1
$1.4M Sell
18,600
-2,700
-13% -$201K 0.16% 56
2022
Q4
$1.68M Hold
21,300
0.21% 51
2022
Q3
$1.5M Hold
21,300
0.2% 52
2022
Q2
$1.71M Sell
21,300
-1,500
-7% -$117K 0.21% 53
2022
Q1
$1.73M Sell
22,800
-2,500
-10% -$198K 0.17% 53
2021
Q4
$2.16M Hold
25,300
0.2% 52
2021
Q3
$1.91M Hold
25,300
0.2% 53
2021
Q2
$2.06M Sell
25,300
-300
-1% -$24.5K 0.21% 52
2021
Q1
$2.02M Sell
25,600
-2,504
-9% -$196K 0.22% 52
2020
Q4
$2.4M Buy
+28,104
New +$2.32M 0.29% 49

Other funds holding CL

Front Barnett Associates's CL Position: Q3 2023 in Review

Front Barnett Associates held its Colgate-Palmolive (CL) position steady in Q3 2023 at 16,600 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #56.

Front Barnett Associates first reported a position in CL in Q4 2020 and has held it in 12 quarters since. The position peaked at $2.4M in Q4 2020. 1,621 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Front Barnett Associates held 16,600 shares of Colgate-Palmolive worth $1.18M as of Q3 2023.
  • Front Barnett Associates left its Colgate-Palmolive share count unchanged in Q3 2023.
  • Colgate-Palmolive made up 0.14% of Front Barnett Associates's portfolio in Q3 2023, its #56 holding.
  • Front Barnett Associates first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 12 quarters since.
  • Front Barnett Associates's Colgate-Palmolive position peaked at $2.4M in Q4 2020.
  • 1,621 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.